Eli Lilly Pipeline

844 Words2 Pages

According to the Eli Lilly SEC filing, “Promotion, marketing, manufacturing, and distribution of human pharmaceutical and animal health products are extensively regulated in all major world markets.”17 In fact, in most major markets, all operations of the company are extremely regulated all at the expense of the company including Federal Drug Administration, U.S. Department of Agriculture, U.S. Environmental Protection Agency, European Medicines Agency, Ministry of Health, Labor and Welfare, Department of Health and Human Services, Federal Trade Commission, Office of Personnel Management. Human Pharmaceuticals, according to the financial statements, in the United States, Eli Lilly promotes to health care professionals by utilizing both an employee based sales force and contracted sales force to call upon physicians and other medical professionals with advertisements being placed in “medical journals, distribute literature and samples of certain products to physicians and exhibit at medical meetings. On the consumer side, websites contain information as well as certain products marketed directly to consumers. Additionally, “special business groups” are used to service wholesalers, pharmacy benefit managers, …show more content…

According to MarketLine, “The current pipeline of Eli Lilly includes many potential opportunities to treat diseases with large unmet need, as well as significant commercial opportunity, and provides the foundation for Eli Lilly to grow significantly in the future and also bridge the period of patent expiry.”20 After entering the diabetes market with some exciting advancements early on in the company’s existence, Eli Lilly continues to dominate this market and is a key area of focus for the company on a global

Show More
Related

  • Regulatory Changes in Direct-To-Consumer Marketing of Pharmaceuticals

    1413 Words  | 3 Pages

    Lyles, Adam. “Direct Marketing of Pharmaceuticals to Consumers.” Annual Review of Public Health, volume 23. 2002. Print.

    Read More

  • Corruption of the Pharmaceutical Industry in America

    2937 Words  | 6 Pages

    In America today, many people are in need of medical help. In fact,the Federal Trade Commission estimates that 75% of the population complain of physical problems (Federal Trade Commission 9). They complain, for example, of fatigue, colds, headaches, and countless other "ailments." When these symptoms strike, 65% purchase over-the counter, or OTC, drugs. In order to take advantage of this demand, five billion dollars is spent by the pharmaceutical industry on marketing each year . This marketing, usually in the form of advert...

    Read More

  • Pros And Cons Of Fda

    892 Words  | 2 Pages

    The Food and Drug Administration (FDA or USFDA) is a federal agency of the United States Department of Health and Human Services, one of the United States federal executive departments. The FDA is responsible for protecting and promoting public health through the regulation and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), cosmetics, animal foods & feed and veterinary products. The FDA was empowered by the United States Congress to enforce the Federal Food, Drug, and Cosmetic Act, which serves as the primary focus for the Agency; the FDA also enforces other laws, notably Section 361 of the Public Health Service Act and associated regulations, many of which are not directly related to food or drugs. The agency also has 223 field offices and 13 laboratories located throughout the 50 states, the United States Virgin Islands, and Puerto Rico.

    Read More

  • Regulating Dietary Supplements

    2092 Words  | 5 Pages

    To begin, the Federal Food and Drug Administration does not have the power to regulate supplements like it does with drugs. Once a product is out on the market, the FDA has to prove that it is dangerous or has illegal additives before it can be removed. The FDA has targeted around seventy tainted weight loss products after learning that they had been mixed with undeclared stimulants, diuretics, and antidepressants (Trebilcock 2). The Federal Food, and Drug, Administration is responsible for ensuring that the manufacturers of foods provide safe ingredients and the correct amount of dosages for their products.

    Read More

  • Drug Patents

    1902 Words  | 4 Pages

    Why do consumers purchase specific drugs for various ailments, sicknesses or diseases they might have? Why do physicians prescribe certain drugs over competitive drugs that may be available to the public? Why is it that most of us can easily name specific drugs that fit the many ailments of today’s society? On the surface the answer might be as simple as good TV advertising or radio commercials or even internet adds. The truth of matter is the major pharmaceutical manufacturers own the patents on these drugs and this gives them all of the marketing budget and muscle they need to promote the drug and control the pricing. The incentives for larger pharmaceutical companies are very enticing and as a result, they don’t mind spending the time in clinical trials and patent courts to get their drugs approved. Some will even get patents on the process by which the drug is manufactured, ensuring that no competitor can steal the drug or the process. This protects their large financial investment and nearly guarantees a large return for their investors. Many consumer rights groups claim this is nothing more than legalizing monopolies for the biggest manufacturers.

    Read More

  • Eli Lilly And Company: The Global Pharmaceutical Company

    1326 Words  | 3 Pages

    Threat of new entrants is relatively high. Companies forming alliances are potential rivals. Even if earlier such company was not considered to be a threat, after merging with some research and development company or forming alliance with another pharmaceutical company it would become a rival to Eli Lilly. The threat is however weakened by significant research and development costs necessary to successfully enter the business. Eli Lilly’s focus on a relatively narrow market of sedatives and antidepressants weakens the threat of new entrants, but other products that form lesser part of company’s sales such as insulin and others are exposed to high threat of new entrants. The need of obtaining certificates and licenses also weakens the threat of new entrants. Discussed above leads to the conclusion that threat of new entrants is medium.

    Read More

  • Kevin Howard Executive Summary

    217 Words  | 1 Pages

    Our products adhere to every environmental and product safety regulation around the world, and we

    Read More

  • Junk Science by Lee Ann Fisher Baron

    1609 Words  | 4 Pages

    U.S. Food and Drug Administration. “CFR -- Code of Federal Regulations Title 21” (21CFR101.9). U.S. Food and Drug Administration. U.S. Department of Health & Human Services, 1 Apr. 2013. Web. 21 Mar. 2014.

    Read More

  • A Business Model Analysis of Eli Lilly and Company

    2081 Words  | 5 Pages

    Colonel Eli Lilly, a pharmacist and veteran of American Civil War, established Eli Lilly and Company in 1867. The headquarters of Eli Lilly and Company is located in Indianapolis, U.S. In more than 135 years running its business, Lilly has several important roles in the development of pharmaceutical industry. In 1923, Lilly introduced Iletin, the world’s first commercially available insulin product, and was among the first companies to develop a method to mass-produce penicillin, the world's first antibiotic.

    Read More

  • Orgasm Inc.: A Case Study

    725 Words  | 2 Pages

    off of their false products, and even when the FDA denied companies rights to market these

    Read More

  • Eli Lilly Case Study

    1311 Words  | 3 Pages

    The pharmaceutical business could be one of the most difficult businesses to stay successful in, and Eli Lilly is attempting to stay successful by dealing with some big problems and important decisions. The biggest problem we face is we will be losing 75 percent of our annual revenue in the next seven years, so we need to find a way to replace or replenish the revenue we will be losing. While making the plan for solving that problem, there are a few factors we need to consider. One is we cannot increase employment of any kind, in fact we recently had to lay off some of our workforce. The factor is we cannot increase our research and development budget, as we recently cut funding for that also. With time also being a factor,

    Read More

  • Insulin Receptor

    2202 Words  | 5 Pages

    Diabetes is a disease that affects millions of Americans everyday. As the years go on, diabetes is becoming more and more prevalent within America. Ongoing research is being done to gain valuable intellect on the disease and for the development of treatments for the disease. There are a few different causes of diabetes but each involves contact with insulin and insulin receptor on some level, since insulin and insulin receptor are involved in the pathway that regulates glucose levels within the body. The insulin/insulin receptor pathway is vital in maintaining homeostasis within the body. As greater information is gathered on the insulin receptor structure and how it functions a better understanding of treatments for diabetes can possibly be unlocked.

    Read More

  • The Ethics of Marketing, Product Safety, and Intellectual Property

    1427 Words  | 3 Pages

    Marketing, intellectual property, and product safety regulation are filled with ethical issues and potential dilemmas that all companies must deal with. PharmaCARE must also consider its actions regarding their use of U.S. copyright law for the drugs it makes, as well as its treatment of its workers. The company needs to decides if it wants to live up to its own brand, or simply go after profits.

    Read More

  • Eli Lilly and Company Case Analysis

    1605 Words  | 4 Pages

    The case under analysis, Eli Lilly & Company, will be covering the positives and negatives with regards to the business situation and strategy of Eli Lilly. One of the major pharmaceutical and health care companies in its industry, Lilly focused its efforts on the areas of "drug research, development, and marketed to the following areas: neuroscience, endocrinology, oncology, cardiovascular disease, and women's health." Having made a strong comeback in the 1990's due to its remarkably successful antidepressant Prozac, was now facing a potential loss in profits with its patent soon to expire. The problem was not only the soon to expire patent on Prozac, but the fact that Prozac accounted for as much as 30% of total revenue was the reality Eli Lilly now faced. (Pearce & Robinson, 34-1)

    Read More

  • Gilead Science Inc Case Study

    749 Words  | 2 Pages

    Gilead Sciences, Inc., is a research-based biopharmaceutical company that discovers, develops, and produces marketable, innovative medicines in areas of under-addressed medical need on a global scale. Gilead 's vast array of products and production of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer and inflammation, and serious respiratory and cardiovascular conditions. Gilead’s product portfolio consists of a number of pharmaceutical firsts, including complete treatment regimens for HIV infection available in a once-daily pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.

    Read More

More about Eli Lilly Pipeline

Open Document